The Scientist

» patent, evolution and immunology

Most Recent

The public may still believe that male-specific traits, such as high testosterone levels, lead to many of the gender inequalities that exist in society, but science tells a different story.

2 Comments

image: Repurposing Existing Drugs for New Indications

Repurposing Existing Drugs for New Indications

By | January 1, 2017

An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.

1 Comment

image: Infographic: Repurposing Strategies

Infographic: Repurposing Strategies

By | January 1, 2017

Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.

0 Comments

image: Fruit Bats Argue Using Nuanced Communication

Fruit Bats Argue Using Nuanced Communication

By | December 29, 2016

Audio recordings of bats hashing out disputes reveals that their calls are laden with information about identity and intent.

0 Comments

image: Life Science Controversies of 2016

Life Science Controversies of 2016

By , , and | December 23, 2016

This year, the developers of CRISPR gene-editing technology argued over patent rights, a researcher fought to unmask anonymous PubPeer commenters, US regulators considered “three-parent” babies, and troubles continued for Theranos.

0 Comments

image: Mouse Immunology Paper Retracted

Mouse Immunology Paper Retracted

By | December 16, 2016

A finding of misconduct spurs the retraction of a Science paper claiming to have identified a protein in mice that boosted immunity to both viruses and cancer.

1 Comment

Standard taxonomy lumps together bird species that should be separate, a new study suggests, raising the total number of estimated species from 9,000 to 18,000.

1 Comment

image: Video: Patent Battle Over CRISPR Gene Editing

Video: Patent Battle Over CRISPR Gene Editing

By | December 13, 2016

The Scientist goes to court for a CRISPR patent interference case at the US Patent and Trademark Office.

0 Comments

image: New Developments in CRISPR Patent Case

New Developments in CRISPR Patent Case

By | December 12, 2016

Documents suggest Feng Zhang started working on CRISPR before Jennifer Doudna’s group published; researchers call for CRISPR technology to be shared openly

0 Comments

image: CRISPR Oral Arguments Recap, Cont’d

CRISPR Oral Arguments Recap, Cont’d

By | December 8, 2016

This week’s CRISPR patent hearing took a deep dive into the science of moving the gene-editing technology from prokaryotes to eukaryotic systems.

2 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS